From the first U.S. Shockwave C2+ case to the unveiling of the 2023 TopShock finalists, this past quarter had a lively pulse all its own. In other news, we’re very excited to share the impressive results from the 2-year DISRUPT CAD III study of IVL for Treatment of Severely Calcified Coronary Arteries.
For our international customers, there was an excellent poster session presented during ESC Congress that featured three presentations on our Coronary Sinus Reducer*. We also launched a series of real-world application videos from VAM 2023 that highlight Shockwave L6 and the benefits of using it to tackle calcium in large vessels. Dive head first into the latest PulsePoint Newsletter to learn more about the big waves made in Q3!
Read More
Topics:
Coronary IVL,
Peripheral IVL,
IVL Technology,
Coronary Clinical Data,
Peripheral Conferences,
Peripheral Clinical Data,
SWAV News,
Shockwave C2,
Coronary Conferences,
Shockwave S4,
PulsePoint Newsletter,
Calcium Corner,
Shockwave M5 & Shockwave M5+,
Reimbursement,
Treating Different Ca++ Morphologies,
Female vs. Male Outcomes,
Empower CAD,
Reducer
Complex PCI can be a real headache, unless you know all the tips and tricks! In this PCR Online webinar, titled "Complex Calcified Lesions: Keep It Simple And Stay Safe", Prof Flavio Ribichini (University of Verona), Dr Claudia Cosgrove (St George's Hospital) and Dr Claudiu Ungureanu (Hôpital de Jolimont) have a lively exchange around modern PCI in calcified lesions.
Read More
Topics:
Coronary IVL,
IVL Technology,
SWAV News,
Shockwave C2
CPT® code +92972 provides an additional 2.97 Work Relative Value Units (RVU) and $140 payment for procedures involving Coronary IVL
Read More
Topics:
Coronary IVL,
IVL Technology,
SWAV News,
Shockwave C2,
Reimbursement
Attending TCT in San Francisco in a few weeks? Come see how we're making waves by the Bay through a lineup of real-world evidence:
Read More
Topics:
Coronary IVL,
IVL Technology,
Shockwave C2,
Coronary Conferences
The results are in. Our expert panel has spoken. Please join us in congratulating the finalists for TopShock 2023!
Read More
Topics:
Coronary IVL,
IVL Technology,
SWAV News,
Shockwave C2,
Reimbursement
Kalzium ist nicht nur oberflächlich ... manchmal muss man in die Tiefe!
Read More
Topics:
Coronary IVL,
IVL Technology,
Shockwave C2,
Coronary Conferences
Over the past three months, Shockwave continued to ride a big wave of momentum with new product launches, inclusions in new journal articles, a pulse-racing presence at EuroPCR and more. The launch of Shockwave L6 Peripheral IVL Catheter in the U.S. came with physician-led case reviews, Q&As and more valuable content that demonstrate the big impact it can make in large peripheral vessels. We also turned up the heat at EuroPCR in Paris, where we showcased live cases, hosted an engaging symposium and participated in PCR TV interviews - all while focusing heavily on the European launch of our Shockwave C2+ Coronary IVL Catheter, which includes 50% more pulses than the original Shockwave C2. Dive right in and catch the wave of excitement in the latest issue of the PulsePoint newsletter!
Read More
Topics:
Coronary IVL,
Peripheral IVL,
IVL Technology,
Coronary Clinical Data,
Peripheral Conferences,
Peripheral Clinical Data,
SWAV News,
Shockwave C2,
Coronary Conferences,
Shockwave S4,
PulsePoint Newsletter,
Calcium Corner,
Shockwave M5 & Shockwave M5+,
Reimbursement,
Treating Different Ca++ Morphologies,
Female vs. Male Outcomes,
Empower CAD
New Medicare Severity Diagnosis Related Groups (MS-DRGs) With Increased Payments Replace Temporary Payment Pathway for Coronary IVL Procedures Within the Hospital Inpatient Setting
Read More
Topics:
Coronary IVL,
IVL Technology,
SWAV News,
Shockwave C2,
Reimbursement
